BrainStorm Granted European Patent Covering its Stem Cells for the Treatment of CNS Diseases

NEW YORK, NY and PETACH TIKVAH, Israel / ACCESSWIRE / September 3, 2014 / BrainStorm Cell Therapeutics (BCLI), a leading developer of adult stem cell technologies for neurodegenerative diseases, today announced that the European Patent Office (EPO) has …

[Read the full article here]

Comments are closed.